John Paulson buys 15 million shares of MTG

Paulson buys MGIC.

It's Wall Street Magic!

Paulson made $3.7 billion in 2007 betting against housing.

Now he's betting with housings.

You have a stock at 6 and change, down from 70.

And you can bet with him!

Apple's new campus

For those wondering why Apple has slowed its product timeline, here is the 128 acre, $6 billion campus.

But in regards to the stock, NO ONE can match Apple's strength in the buyback of their stock. Every marginally seller will be sucked up by Apple, and the floor on Apple is found.

  Submittal 6

Wall Street to Tim Cook--You are lying!

New products? Innovation? Tim Cook you are lying. At least so says Wall Street. If the stock is so cheap, why not buy it all now? Unless of course this quarter and next quarter are in the toilet also. Wall Street wants to hear none of Mr. Cook, as he repulsed the analysts on the conference call last night. Wall Street, though is respectful, and they won't show it on the call, but they will on the downgrades of the stock, and today, they got a slew of them, as they vehemently, in the only way that Wall Street can, tell Tim Cook to go and screw himself in the only way they can!

Tim Cooks says sorry to China, but lies to Wall Street. Cook breaks the code, instead of having Apple engineers write some code on iOS, for a 5" screen, and then, he disengeniously calls the lack of code writing a "trade-off." On Wall Street you tell the truth, and you man up. You don't hide behind platitudes of bullsh*t.

So Wall Street gives Tim Cook the finger today, and here is an example.

Apple removed from Focus List, target cut to $545 at JPMorgan
 JPMorgan removed Apple from its Analyst Focus List and lowered its price target for shares to $545 from $725 following the company's Q2 results. The firm thinks Apple's June quarter outlook could weigh on shares over the short-term, but feels the company's buyback and dividend boost could set a floor in the stock. JPMorgan keeps an Overweight rating on Apple.

 Apple price target lowered to $500 from $575 at Goldman.
 Goldman lowered Apple estimates but continues to believe new product cycles will remedy current challenges. Shares are Buy rated.

Apple multiples likely permanently lowered, says Oppenheimer 
After Apple reported in-line EPS for its March quarter but provided June quarter guidance that the firm views as weak, Oppenheimer thinks that several factors, including negative mix changes and increased competition, will cause the company's multiples to be "permanently hurt." The firm thinks that the shares are likely to be range bound until the company's next product cycle, which it believes will "make or break the stock." Nevertheless the firm keeps an Outperform rating on the shares.

Apple downgraded to Market Perform from Outperform at BMO Capital
 BMO Capital downgraded Apple to reflect longer-term concerns regarding the "trade off" for revenue growth vs. margins and the impact of increased competition on ASP's, which will offset improved capital allocation. The firm lowered estimates and reduced its price target lowered to $435 from $440.

Apple price target lowered to $480 from $575 at Deutsche Bank
Deutsche Bank lowered its estimates and price target for Apple due to lower margin assumptions following the company's Q2 results. The firm notes that Apple management did not confirm the June quarter will be a margin trough. Deutsche says Apple's buyback and increased dividend do not hide the fact that new products need to be introduced. The firm maintains a Buy rating on the stock despite dropping its estimates and price target.

Apple price target lowered to $475 from $505 at CLSA
CLSA lowered Apple estimates but said its shares price is discounting lower gross margins. The firm believes shares can outperform as new product cycles and the $60B buyback kick in and maintains its Outperform rating.

Apple price target lowered to $430 from $480 at Citigroup
Citigroup says Apple's below-consensus guidance partially nullifies the positive earnings impact from its big buyback increase. Citi expects investor attention to focus on Apple's weakening fundamentals now that the capital allocation catalyst is removed. The firm keeps a Neutral rating on the stock with a lower price target following Apple's Q2 results.